Semax Peptide
Pathway Genes
Biomeme does not prescribe, supply, recommend or evaluate this therapy. This page describes which genes it acts on, not whether you should take it.
There are no published human clinical trials of this peptide.
Semax is a synthetic ACTH(4-10) analogue, registered in Russia and Ukraine and not approved in the United States. This page describes the genes associated with it. Note that BDNF and NTRK2 are principally brain transcripts and are not measurable from a blood sample.
Tracked Physiological Dimensions
On the Advanced Transcriptomics Dashboard, Semax is tracked across the cellular stress dimension.
Stress Response Gene Regulation
Semax has been investigated in preclinical models for its influence on neurotrophin pathways and cellular stress responses.
This panel reports the transcription of HSPA1A and FOS in circulating cells.
Key Target Genes
Brain-Derived Neurotrophic Factor Neuroplasticity
Neurotrophic factor associated with synaptic plasticity. Principally a brain transcript.
Neurotrophic Receptor Tyrosine Kinase 2 BDNF Signaling
The primary high-affinity receptor for BDNF. Principally a brain transcript.
Heat Shock Protein 70 Hypoxic Defense
Chaperone induced by proteotoxic stress.
FOS Proto-Oncogene Immediate-Early Response
Transcription factor indicating rapid cellular adaptation and synaptic activation.
The Biomeme Molecular Ecosystem
From deep whole-transcriptome sequencing in the laboratory to rapid point-of-care instrumentation in the field.
High-Depth RNA Sequencing
Processed at One Health Labs, Biomeme's CLIA-certified laboratory, using Illumina NovaSeq high-depth paired-end RNA sequencing. Samples are collected in venous PAXgene blood RNA tubes to stabilize cellular transcription at the moment of draw.
Biomeme/5 Handheld Platform
Beyond central-lab genomics, Biomeme engineers patented, battery-powered real-time PCR instruments. Our deployable hardware brings decentralized molecular detection directly to the field and clinical points of care.
Curious how we measure this?
Learn about the foundational science of Transcriptomics and how Biomeme brings molecular profiling to the point of need.
Ready to Learn More?
Explore how Biomeme's capabilities are being deployed across the Wellness landscape.
ABOUT THESE PANELS
Biomeme's wellness transcriptomic panels are general wellness products. They report gene activity to support a healthy lifestyle. They are not intended to diagnose, treat, cure, mitigate or prevent any disease or condition, and they are not a substitute for evaluation by a licensed healthcare professional. Results describe the state of the measured transcripts at the moment the sample was taken.